Asset Details
Do you wish to reserve the book?
Understanding the somatic consequences of depression: biological mechanisms and the role of depression symptom profile
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Understanding the somatic consequences of depression: biological mechanisms and the role of depression symptom profile
Do you wish to request the book?
Understanding the somatic consequences of depression: biological mechanisms and the role of depression symptom profile
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Understanding the somatic consequences of depression: biological mechanisms and the role of depression symptom profile
2013
Overview
Depression is the most common psychiatric disorder worldwide. The burden of disease for depression goes beyond functioning and quality of life and extends to somatic health. Depression has been shown to subsequently increase the risk of, for example, cardiovascular, stroke, diabetes and obesity morbidity. These somatic consequences could partly be due to metabolic, immuno-inflammatory, autonomic and hypothalamic-pituitary-adrenal (HPA)-axis dysregulations which have been suggested to be more often present among depressed patients. Evidence linking depression to metabolic syndrome abnormalities indicates that depression is especially associated with its obesity-related components (for example, abdominal obesity and dyslipidemia). In addition, systemic inflammation and hyperactivity of the HPA-axis have been consistently observed among depressed patients. Slightly less consistent observations are for autonomic dysregulation among depressed patients. The heterogeneity of the depression concept seems to play a differentiating role: metabolic syndrome and inflammation up-regulations appear more specific to the atypical depression subtype, whereas hypercortisolemia appears more specific for melancholic depression. This review finishes with potential treatment implications for the downward spiral in which different depressive symptom profiles and biological dysregulations may impact on each other and interact with somatic health decline.
Publisher
BioMed Central,BioMed Central Ltd,Springer Nature B.V
Subject
/ Complications and side effects
/ Current Controversies in Psychiatry
/ Depression - physiopathology
/ Exercise
/ Humans
/ Kinases
/ Medicine
/ Metabolic Syndrome - epidemiology
/ Metabolic Syndrome - etiology
/ Metabolic Syndrome - prevention & control
/ Review
/ Studies
/ Towards a new psychiatry: Philosophical and ethical issues in classification
